Opinion: Axis’ abortive reinsurance sale exacerbates its challenges
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Email
  • Free Trial
  • Log in

Opinion: Axis’ abortive reinsurance sale exacerbates its challenges

Rachel Dalton
11 May 2022
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Email
axis-new-with-benchimol-bermuda.jpg

Axis Capital’s sudden decision to pull the sale of its reinsurance unit – just a matter of weeks after putting it on the market – is a step that will make matters more difficult for the Bermudian.

This publication revealed in late April that Axis had appointed Jefferies to manage the sale of the ~$3bn unit.

The

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Request a free trial Already a subscriber? Log in now

Topics

Opinion M&A Axis Capital
rachel dalton/rachel dalton ii red.png
Rachel Dalton
Lead Reporter
Contact
Gift this article